A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate

A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate

**Background/Objectives:** This article compares the effectiveness of baricitinib (BARI) 4 mg (oral, Janus kinase [JAK] 1/2 inhibitor) versus other targeted synthetic/biologic disease-modifying antirheumatic drugs, in combination with methotrexate (MTX), in moderate-to-severe rheumatoid arthritis pa...

Full description

Bibliographic Details
Main Authors: Walid Fakhouri, Xiaofei Wang, Inmaculada de La Torre, Claudia Nicolay
Format: Article
Language:English
Published: Columbia Data Analytics, LLC
Series:Journal of Health Economics and Outcomes Research
Online Access:http://jheor.scholasticahq.com/article/12273-a-network-meta-analysis-to-compare-effectiveness-of-baricitinib-and-other-treatments-in-rheumatoid-arthritis-patients-with-inadequate-response-to-methotrexate.pdf

Internet

http://jheor.scholasticahq.com/article/12273-a-network-meta-analysis-to-compare-effectiveness-of-baricitinib-and-other-treatments-in-rheumatoid-arthritis-patients-with-inadequate-response-to-methotrexate.pdf

Similar Items